Since PI3K–Akt–mTOR axis abnormalities are implicated in the etiology of GBM and other types of brain tumors [19,28,29,30], the activation of the mTOR pathway in the CNS is a subject of intense research. This evidence concerns the gene MTOR and glioblastoma.